Compare Mutual Funds
Select a Mutual Fund
Risk | Very High | - |
Rating | 1.0 | - |
Min SIP Amount | ₹1000 | - |
Expense Ratio | 0.98 | - |
NAV | ₹16.35 | - |
Fund Started | 25 Nov 2022 | - |
Fund Size | ₹94.36 Cr | - |
Exit Load | - | - |
Risk
Very High
-
Rating
1.0
-
Min SIP Amount
₹1000
-
Expense Ratio
0.98
-
NAV
₹16.35
-
Fund Started
25 Nov 2022
-
Fund Size
₹94.36 Cr
-
Exit Load
-
-
1 Year | -1.60% | - |
3 Year | 18.68% | - |
5 Year | - | - |
1 Year
-1.60%
-
3 Year
18.68%
-
5 Year
-
-
Equity | 99.95% | - |
Cash | 0.05% | - |
Equity
99.95%
-
Cash
0.05%
-
Top 10 Holdings |
| - |
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 22.05% |
Cipla Ltd. | 10.30% |
Divi's Laboratories Ltd. | 9.84% |
Dr. Reddy's Laboratories Ltd. | 9.38% |
Lupin Ltd. | 6.19% |
Laurus Labs Ltd. | 5.21% |
Torrent Pharmaceuticals Ltd. | 4.88% |
Aurobindo Pharma Ltd. | 4.01% |
Alkem Laboratories Ltd. | 3.90% |
Glenmark Pharmaceuticals Ltd. | 3.71% |
-
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The Scheme seeks to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index | - |
Launch Date | 25 Nov 2022 | - |
Description
The Scheme seeks to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index
-
Launch Date
25 Nov 2022
-